S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
OTCMKTS:CHEOF

Cochlear Stock Forecast, Price & News

$155.13
-7.25 (-4.46%)
(As of 11/30/2021 03:29 PM ET)
Add
Compare
Today's Range
$150.50
$160.00
50-Day Range
$155.13
$171.00
52-Week Range
$137.75
$185.30
Volume
181 shs
Average Volume
355 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive CHEOF News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.


Cochlear logo

About Cochlear

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CHEOF
Fax
N/A
Employees
4,000
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Cochlear (OTCMKTS:CHEOF) Frequently Asked Questions

How has Cochlear's stock been impacted by Coronavirus?

Cochlear's stock was trading at $129.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CHEOF stock has increased by 20.3% and is now trading at $155.1250.
View which stocks have been most impacted by COVID-19
.

Who are Cochlear's key executives?

Cochlear's management team includes the following people:
  • Diggory William Howitt, President, CEO, Executive Director & MD
  • Stuart Sayers, Chief Financial Officer & President-Services
  • Jan Janssen, Chief Technology Officer
  • David Hackshall, Chief Information Officer
  • Matthew Prior, VP-Finance & Commercial Operations-Asia Pacific

What is Cochlear's stock symbol?

Cochlear trades on the OTCMKTS under the ticker symbol "CHEOF."

How do I buy shares of Cochlear?

Shares of CHEOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cochlear's stock price today?

One share of CHEOF stock can currently be purchased for approximately $155.13.

How many employees does Cochlear have?

Cochlear employs 4,000 workers across the globe.

What is Cochlear's official website?

The official website for Cochlear is www.cochlear.com.

Where are Cochlear's headquarters?

Cochlear is headquartered at 1 University Avenue, Sydney, New South.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue, Sydney, New South. The company can be reached via phone at (129) 428-6555.


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.